-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-8 Advances in Mass Spectrometry for Myeloma Minimal Residual Disease

Program: Scientific Program
Session: Getting the Most from Minimal Residual Disease
Hematology Disease Topics & Pathways:
Technology and Procedures
Sunday, December 6, 2020, 1:55 PM-2:00 PM

Katie Thoren

Memorial Sloan Kettering Cancer Center, New York, NY

Disclosures: Thoren: Sebia: Research Funding; The Binding Site: Research Funding.